EMN
Eastman Chemical Company NYSE$76.72
Mkt Cap $8.8B
52w Low $56.11
73.4% of range
52w High $84.18
50d MA $72.63
200d MA $67.76
P/E (TTM)
18.8x
EV/EBITDA
9.2x
P/B
1.5x
Debt/Equity
0.8x
ROE
8.0%
P/FCF
17.3x
RSI (14)
—
ATR (14)
—
Beta
1.17
50d MA
$72.63
200d MA
$67.76
Avg Volume
1.6M
About
Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and co…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.07 | 1.09 | +1.9% | 73.09 | +3.0% | +6.1% | — | — | — | — | — | — |
| Jan 29, 2026 | AMC | 0.76 | 0.75 | -1.3% | 68.99 | +2.1% | +0.5% | +3.6% | +10.0% | +13.8% | +10.3% | +9.1% | — |
| Nov 3, 2025 | AMC | 1.16 | 1.14 | -1.7% | 57.89 | +1.7% | +4.9% | +5.5% | +3.0% | +5.8% | +6.3% | +6.4% | — |
| Jul 31, 2025 | AMC | 1.72 | 1.60 | -7.0% | 72.61 | -12.2% | -19.0% | -16.3% | -15.5% | -16.1% | -15.6% | -4.4% | — |
| Apr 24, 2025 | AMC | 1.89 | 1.91 | +1.1% | 80.82 | -4.6% | -6.2% | -6.3% | -5.7% | -4.7% | -5.7% | +2.0% | — |
| Jan 30, 2025 | AMC | 1.60 | 1.87 | +16.9% | 92.67 | +8.9% | +7.5% | +8.8% | +9.8% | +9.8% | +9.3% | +1.9% | — |
| Oct 31, 2024 | AMC | 2.14 | 2.26 | +5.6% | 105.09 | -2.9% | -3.8% | -4.8% | -4.0% | -1.3% | -1.5% | -0.8% | — |
| Jul 25, 2024 | AMC | 2.01 | 2.15 | +7.0% | 97.14 | +1.1% | +3.7% | +4.2% | +6.3% | +6.4% | +4.7% | +4.0% | — |
| Apr 25, 2024 | AMC | 1.43 | 1.61 | +12.6% | 96.13 | -0.1% | -0.6% | +1.3% | -1.8% | -1.4% | -0.2% | +4.8% | — |
| Feb 1, 2024 | AMC | 1.28 | 1.31 | +2.3% | 84.86 | -3.0% | -2.7% | -2.7% | -2.7% | -2.2% | -2.2% | +3.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | Citigroup | Maintains | Buy → Buy | — | $72.75 | $73.00 | +0.3% | +0.8% | +1.4% | +1.2% | -0.4% | -0.3% |
| Apr 14 | JP Morgan | Upgrade | Neutral → Overweight | — | $74.01 | $75.59 | +2.1% | -0.3% | -1.7% | -0.9% | -0.3% | -0.5% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $74.27 | $74.60 | +0.4% | -2.1% | -0.0% | -0.4% | -0.6% | -2.0% |
| Mar 12 | Citigroup | Maintains | Buy → Buy | — | $67.72 | $67.67 | -0.1% | +4.2% | +2.3% | +2.7% | +5.2% | +1.8% |
| Feb 18 | Evercore ISI | Maintains | In Line → In Line | — | $79.11 | $79.73 | +0.8% | +1.5% | -1.4% | +0.1% | -3.2% | -2.5% |
| Feb 3 | Citigroup | Maintains | Buy → Buy | — | $71.48 | $72.00 | +0.7% | +6.2% | +9.8% | +6.4% | +8.3% | +9.7% |
| Feb 2 | BofA Securities | Maintains | Buy → Buy | — | $69.32 | $68.99 | -0.5% | +3.1% | +9.5% | +13.2% | +9.8% | +11.7% |
| Feb 2 | JP Morgan | Maintains | Neutral → Neutral | — | $69.32 | $68.99 | -0.5% | +3.1% | +9.5% | +13.2% | +9.8% | +11.7% |
| Feb 2 | Deutsche Bank | Maintains | Hold → Hold | — | $69.32 | $68.99 | -0.5% | +3.1% | +9.5% | +13.2% | +9.8% | +11.7% |
| Jan 16 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $70.23 | $69.01 | -1.7% | -2.2% | -5.8% | -2.7% | -1.8% | -2.2% |
Recent Filings
Data updated apr 25, 2026 7:05am
· Source: massive.com